Anavex Research Development vs Ebit Analysis

Stocks . USA . 
Stock . Anavex Life Sciences
AVXL Stock  USD 9.11  0.09  1.00%   
Anavex Life financial indicator trend analysis is way more than just evaluating Anavex Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Anavex Life Sciences is a good investment. Please check the relationship between Anavex Life Research Development and its Ebit accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Research Development vs Ebit

Research Development vs Ebit Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Anavex Life Sciences Research Development account and Ebit. At this time, the significance of the direction appears to have pay attention.
The correlation between Anavex Life's Research Development and Ebit is -0.79. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Ebit in the same time period over historical financial statements of Anavex Life Sciences, assuming nothing else is changed. The correlation between historical values of Anavex Life's Research Development and Ebit is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Anavex Life Sciences are associated (or correlated) with its Ebit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebit has no effect on the direction of Research Development i.e., Anavex Life's Research Development and Ebit go up and down completely randomly.

Correlation Coefficient

-0.79
Relationship DirectionNegative 
Relationship StrengthWeak

Research Development

Ebit

Most indicators from Anavex Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
At this time, Anavex Life's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 47.1 M this year, although Enterprise Value Over EBITDA will most likely fall to (6.30).
 2021 2022 2023 2024 (projected)
Tax Provision358.5K7K8.1K7.6K
Interest Income947.0K6.5M7.5M7.9M

Anavex Life fundamental ratios Correlations

Total Assets
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Net Debt
Retained Earnings
Cash
Cash And Short Term Investments
Common Stock Total Equity
Common Stock Shares Outstanding
Other Stockholder Equity
Total Liab
Total Current Assets
Common Stock
Accounts Payable
Short Long Term Debt Total
Other Current Assets
Short Term Debt
Property Plant And Equipment Net
Current Deferred Revenue
Non Current Assets Total
Property Plant And Equipment Gross
Non Current Liabilities Total
Net Receivables
Net Tangible Assets
Other Assets
Total Assets
0.930.961.0-0.98-0.931.01.00.90.910.980.931.00.910.78-0.220.05-0.36-0.080.58-0.26-0.080.850.641.00.32
Other Current Liab
0.930.960.93-0.88-0.910.930.930.890.910.960.910.930.910.79-0.270.01-0.27-0.10.71-0.11-0.10.80.420.930.2
Total Current Liabilities
0.960.960.96-0.93-0.960.960.960.950.960.990.960.960.950.85-0.280.14-0.32-0.110.69-0.27-0.110.850.630.960.22
Total Stockholder Equity
1.00.930.96-0.98-0.931.01.00.890.910.980.931.00.90.78-0.240.04-0.37-0.090.56-0.26-0.090.840.641.00.33
Net Debt
-0.98-0.88-0.93-0.980.93-0.98-0.98-0.87-0.88-0.95-0.89-0.98-0.87-0.760.25-0.040.360.11-0.550.240.11-0.79-0.68-0.98-0.4
Retained Earnings
-0.93-0.91-0.96-0.930.93-0.93-0.93-0.94-0.97-0.97-0.93-0.93-0.95-0.870.25-0.240.380.08-0.710.220.08-0.8-0.61-0.93-0.33
Cash
1.00.930.961.0-0.98-0.931.00.90.910.980.931.00.910.78-0.220.04-0.35-0.080.57-0.26-0.080.850.621.00.33
Cash And Short Term Investments
1.00.930.961.0-0.98-0.931.00.90.910.980.931.00.910.78-0.220.04-0.35-0.080.57-0.26-0.080.850.621.00.33
Common Stock Total Equity
0.90.890.950.89-0.87-0.940.90.90.930.940.960.91.00.88-0.080.21-0.210.120.83-0.210.120.860.620.890.26
Common Stock Shares Outstanding
0.910.910.960.91-0.88-0.970.910.910.930.960.90.910.940.93-0.320.29-0.48-0.120.71-0.08-0.120.740.610.910.27
Other Stockholder Equity
0.980.960.990.98-0.95-0.970.980.980.940.960.960.980.950.84-0.240.14-0.37-0.070.66-0.25-0.070.860.580.980.28
Total Liab
0.930.910.960.93-0.89-0.930.930.930.960.90.960.930.970.790.020.09-0.220.10.71-0.330.10.960.590.930.2
Total Current Assets
1.00.930.961.0-0.98-0.931.01.00.90.910.980.930.910.78-0.220.05-0.36-0.080.58-0.26-0.080.850.641.00.32
Common Stock
0.910.910.950.9-0.87-0.950.910.911.00.940.950.970.910.87-0.080.2-0.210.110.82-0.220.110.870.60.90.24
Accounts Payable
0.780.790.850.78-0.76-0.870.780.780.880.930.840.790.780.87-0.320.32-0.520.050.760.080.050.610.620.780.13
Short Long Term Debt Total
-0.22-0.27-0.28-0.240.250.25-0.22-0.22-0.08-0.32-0.240.02-0.22-0.08-0.32-0.170.370.59-0.06-0.130.590.21-0.2-0.24-0.08
Other Current Assets
0.050.010.140.04-0.04-0.240.040.040.210.290.140.090.050.20.32-0.17-0.25-0.090.290.02-0.09-0.010.160.05-0.07
Short Term Debt
-0.36-0.27-0.32-0.370.360.38-0.35-0.35-0.21-0.48-0.37-0.22-0.36-0.21-0.520.37-0.250.20.09-0.180.2-0.12-0.28-0.36-0.1
Property Plant And Equipment Net
-0.08-0.1-0.11-0.090.110.08-0.08-0.080.12-0.12-0.070.1-0.080.110.050.59-0.090.20.18-0.071.00.19-0.11-0.09-0.05
Current Deferred Revenue
0.580.710.690.56-0.55-0.710.570.570.830.710.660.710.580.820.76-0.060.290.090.180.040.180.550.340.570.07
Non Current Assets Total
-0.26-0.11-0.27-0.260.240.22-0.26-0.26-0.21-0.08-0.25-0.33-0.26-0.220.08-0.130.02-0.18-0.070.04-0.07-0.47-0.24-0.25-0.16
Property Plant And Equipment Gross
-0.08-0.1-0.11-0.090.110.08-0.08-0.080.12-0.12-0.070.1-0.080.110.050.59-0.090.21.00.18-0.070.19-0.11-0.09-0.05
Non Current Liabilities Total
0.850.80.850.84-0.79-0.80.850.850.860.740.860.960.850.870.610.21-0.01-0.120.190.55-0.470.190.520.840.1
Net Receivables
0.640.420.630.64-0.68-0.610.620.620.620.610.580.590.640.60.62-0.20.16-0.28-0.110.34-0.24-0.110.520.640.14
Net Tangible Assets
1.00.930.961.0-0.98-0.931.01.00.890.910.980.931.00.90.78-0.240.05-0.36-0.090.57-0.25-0.090.840.640.33
Other Assets
0.320.20.220.33-0.4-0.330.330.330.260.270.280.20.320.240.13-0.08-0.07-0.1-0.050.07-0.16-0.050.10.140.33
Click cells to compare fundamentals

Anavex Life Account Relationship Matchups

High Positive Relationship

Total Stockholder Equity
+ 1.0
Total Assets
Cash
+ 1.0
Total Assets
Cash And Short Term Investments
+ 1.0
Total Assets
Total Current Assets
+ 1.0
Total Assets
Net Tangible Assets
+ 1.0
Total Assets
Cash
+ 1.0
Total Stockholder Equity

High Negative Relationship

Net Tangible Assets
- 0.98
Net Debt
Total Current Assets
- 0.98
Net Debt
Cash And Short Term Investments
- 0.98
Net Debt
Cash
- 0.98
Net Debt
Net Debt
- 0.98
Total Stockholder Equity
Net Debt
- 0.98
Total Assets

Anavex Life fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets34.5M161.6M152.7M154.4M177.5M186.4M
Other Current Liab3.3M5.6M6.4M8.2M9.4M9.9M
Total Current Liabilities7.3M10.8M10.2M12.5M14.4M15.1M
Total Stockholder Equity27.2M150.8M142.5M141.9M163.1M171.3M
Net Debt(29.2M)(152.1M)(149.2M)(151.0M)(135.9M)(129.1M)
Retained Earnings(159.7M)(197.6M)(245.6M)(293.1M)(263.8M)(250.6M)
Cash29.2M152.1M149.2M151.0M173.7M182.4M
Cash And Short Term Investments29.2M152.1M149.2M151.0M173.7M182.4M
Common Stock Total Equity52.7K62.0K75.9K77.9K89.6K94.1K
Common Stock Shares Outstanding58.2M69.8M76.9M79.8M91.8M96.3M
Liabilities And Stockholders Equity34.5M161.6M152.7M154.4M177.5M186.4M
Other Stockholder Equity186.9M348.3M388.0M434.8M500.1M525.1M
Total Liab7.3M10.8M10.2M12.5M14.4M15.1M
Total Current Assets34.5M161.6M152.7M154.4M177.5M186.4M
Common Stock62.0K75.9K77.9K82K94.3K99.0K
Accounts Payable4.0M4.7M3.8M4.3M5.0M5.2M
Other Current Assets443.8K371.9K354K653K751.0K496.3K
Non Current Liabilities Total3.3M5.6M4.3M7.3M8.4M8.8M
Net Receivables4.8M9.1M3.2M2.7M3.1M2.1M
Net Tangible Assets27.2M150.8M142.5M141.9M163.1M171.3M
Retained Earnings Total Equity(133.4M)(159.7M)(197.6M)(245.6M)(221.0M)(210.0M)
Capital Surpluse153.6M186.9M348.3M388.0M446.2M468.5M
Net Invested Capital27.2M150.8M142.5M141.9M163.1M82.9M
Net Working Capital27.2M150.8M142.5M141.9M163.1M82.9M
Capital Stock62.0K75.9K77.9K82K94.3K72.7K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:
How To Invest In Anavex
Details
Is Anavex Stock a good investment?
Details
What is Anavex Life's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.51)
Return On Assets
(0.20)
Return On Equity
(0.30)
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY